Depth over breadth: Piramal Consumer Healthcare takes a leaf out of the modern FMCG playbook

Anil Agarwal’s firm tells NCLAT that lenders ignored its superior bid, questioning transparency and fairness in the high-stakes insolvency case…

Cipla is developing a biosimilars pipeline, with plans to add 1-2 products yearly for the next five years. The drugmaker…